FDA inspection
Rosemont Pharmaceuticals Ltd.: FDA inspection ending Apr 24, 2026
FDA inspection 1320962 · No Action Indicated (NAI) · Leeds
Key facts
| Inspection ID | 1320962 |
|---|---|
| Firm | Rosemont Pharmaceuticals Ltd. |
| FEI number | 3002442738 |
| Address | Rosemont House, Yorkdale Industrial Park |
| City | Leeds |
| Country | United Kingdom |
| Fiscal year | 2026 |
| Inspection end date | Apr 24, 2026 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data